Cambridge Antibody Technology Group Ltd

Cambridge Antibody Technology Group plc develops technologies for the rapid isolation of human monoclonal antibodies. The Company's products are used in the development of antibody-based human therapeutics, as well as in drug discovery processes. Cambridge Antibody also has licenses and joint agreements with pharmaceutical and technology companies worldwide.